Savior Lifetec Corporation (4167.TWO)

25.50 -0.65 (-2.49%) At close: 01:30PM CST

Savior Lifetec Corporation

No. 29, Ke-Jhong Road
Chunan Chen Hsinchu Science Park
Miaoli 35053
Taiwan
886 3 758 0100
https://www.saviorlifetec.com.tw/en/

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Chih-Fang Chen	President & Managerial Officer	N/A	N/A	N/A
Kuo-Wei Lin	Financial Officer	N/A	N/A	N/A
Chu-Yuan Huang	Accounting Officer	N/A	N/A	N/A
Mr. Chia-Chu Chou	Representative Director & Assistant VP	2.41M	N/A	1982
Fang Zhen Xu	Head of Internal Audit	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various products, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

Corporate governance

Savior Lifetec Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.